Digbi Health Expands GLP Compass, Introduces New Products

Got story updates? Submit your updates here. ›

Digbi Health, a health technology company based in Mountain View, California, has announced the expansion of its GLP Compass platform and the introduction of new products. The company is positioning itself to capitalize on the growing market for GLP-1 (glucagon-like peptide-1) medications and therapies.

Why it matters

The GLP-1 market has seen significant growth in recent years, driven by the increasing prevalence of type 2 diabetes and obesity. Digbi Health's expansion of its GLP Compass platform and new product offerings aim to provide healthcare providers and patients with more comprehensive solutions in this rapidly evolving space.

The details

Digbi Health's GLP Compass is a platform that helps healthcare providers and patients manage GLP-1 therapies more effectively. The company has announced the expansion of this platform, which now includes additional features and functionalities to support the growing demand for GLP-1 treatments. Additionally, Digbi Health has introduced new products that complement its GLP Compass offerings, further strengthening its position in the market.

• Digbi Health announced the expansion of its GLP Compass platform and the introduction of new products on March 17, 2026.

What’s next

Digbi Health plans to continue expanding its GLP Compass platform and introducing new products to meet the growing demand for GLP-1 treatments in the healthcare market.